Literature DB >> 27377536

The contribution of neutrophils to CNS autoimmunity.

Emily R Pierson1, Catriona A Wagner1, Joan M Goverman2.   

Abstract

Multiple sclerosis (MS) is believed to be initiated when myelin-specific T cells infiltrate the central nervous system (CNS), triggering subsequent recruitment of inflammatory leukocytes to the CNS. The contribution of neutrophils to CNS autoimmune disease has been underappreciated, but several studies in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, indicate that neutrophils have an important role in inflammation. Neutrophils are hypothesized to contribute to the pathogenesis of EAE by producing cytokines and promoting breakdown of the blood brain barrier. Neutrophils may also influence the manifestation of EAE by facilitating parenchymal brain inflammation. This review summarizes evidence supporting a functional role for neutrophils in EAE and MS, highlighting the differential regulation of neutrophil recruitment in the brain and spinal cord.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCR2; EAE; IL-17; MS; Neutrophils

Mesh:

Substances:

Year:  2016        PMID: 27377536      PMCID: PMC5203971          DOI: 10.1016/j.clim.2016.06.017

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  63 in total

1.  Neutrophils in multiple sclerosis are characterized by a primed phenotype.

Authors:  Matthias Naegele; Kati Tillack; Stefanie Reinhardt; Sven Schippling; Roland Martin; Mireia Sospedra
Journal:  J Neuroimmunol       Date:  2011-12-09       Impact factor: 3.478

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

Review 3.  Stage-specific immune dysregulation in multiple sclerosis.

Authors:  Benjamin M Segal
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

4.  Clinical characteristics, course and prognosis of spinal multiple sclerosis.

Authors:  V Nociti; A Cianfoni; M Mirabella; M Caggiula; G Frisullo; A K Patanella; C Sancricca; F Angelucci; P A Tonali; A P Batocchi
Journal:  Spinal Cord       Date:  2005-12       Impact factor: 2.772

5.  Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.

Authors:  Joshua S Stoolman; Patrick C Duncker; Amanda K Huber; Benjamin M Segal
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction.

Authors:  D M Muller; M P Pender; J M Greer
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

7.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

8.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  Neutrophil-related factors as biomarkers in EAE and MS.

Authors:  Julie M Rumble; Amanda K Huber; Gurumoorthy Krishnamoorthy; Ashok Srinivasan; David A Giles; Xu Zhang; Lu Wang; Benjamin M Segal
Journal:  J Exp Med       Date:  2015-01-05       Impact factor: 14.307

10.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors:  Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

View more
  35 in total

1.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

Review 2.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

3.  IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells.

Authors:  Alexandre Paré; Benoit Mailhot; Sébastien A Lévesque; Camille Juzwik; Prenitha Mercy Ignatius Arokia Doss; Marc-André Lécuyer; Alexandre Prat; Manu Rangachari; Alyson Fournier; Steve Lacroix
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

Review 4.  Neuroprotection through G-CSF: recent advances and future viewpoints.

Authors:  Vikrant Rahi; Sumit Jamwal; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2021-01-02       Impact factor: 3.024

5.  Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.

Authors:  Eiji Saito; Robert Kuo; Ryan M Pearson; Nishant Gohel; Brandon Cheung; Nicholas J C King; Stephen D Miller; Lonnie D Shea
Journal:  J Control Release       Date:  2019-02-27       Impact factor: 9.776

6.  Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.

Authors:  James A Rogers; Manoj K Mishra; Jennifer Hahn; Catherine J Greene; Robin M Yates; Luanne M Metz; V Wee Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

7.  Synthesis and Biological Evaluation of Subglutinol Analogs for Immunomodulatory Agents.

Authors:  Hyeri Park; Laura S Christian; Mi Jung Kim; Qi-Jing Li; Jiyong Hong
Journal:  J Med Chem       Date:  2019-12-18       Impact factor: 7.446

8.  TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.

Authors:  Masato Tsutsui; Ryo Hirase; Sakie Miyamura; Kazuki Nagayasu; Takayuki Nakagawa; Yasuo Mori; Hisashi Shirakawa; Shuji Kaneko
Journal:  J Neurosci       Date:  2018-09-10       Impact factor: 6.167

9.  Kruppel-like factor 4 regulates neutrophil activation.

Authors:  Yuyan Shen; Hong Hong; Panjamaporn Sangwung; Stephanie Lapping; Lalitha Nayak; Lilei Zhang; Mukesh K Jain; Xudong Liao
Journal:  Blood Adv       Date:  2017-04-20

Review 10.  Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.

Authors:  M J Mansilla; S Presas-Rodríguez; A Teniente-Serra; I González-Larreategui; B Quirant-Sánchez; F Fondelli; N Djedovic; D Iwaszkiewicz-Grześ; K Chwojnicki; Đ Miljković; P Trzonkowski; C Ramo-Tello; E M Martínez-Cáceres
Journal:  Cell Mol Immunol       Date:  2021-05-06       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.